1.Prevalence and influencing factors for cervical discomfort in medical staff
Qing-Po HU ; Shao-Yan LU ; Jian-Hong GU ; Hong MIAO ; Jing WANG
Journal of Preventive Medicine 2018;30(7):688-692
Objective To understand status and influencing factors for cervical discomfort in medical staff and to provide evidence for cervical spondylosis control. Methods We made a cervical discomfort questionnaire for medical personnel, including information about demography, life style, occupational hazard and symptoms of cervical discomfort. Then we carried out a survey from May to July 2017 in a hospital and used logistic regression model to analyze the influencing factors for cervical discomfort in medical staff. Results There were 965 medical staff participated in the survey, the response rate was 79.88% (965/1 208) . A total of 454 cases reported to have cervical discomfort, the prevalence was 47.05%. The results of multiple logistic regression analysis showed that years of service (OR4-10=2.551, 95% CI: 1.683-3.861; OR >10=1.767, 95% CI:1.325-2.358), air pollution in the workplace (ORgeneral=0.612, 95%CI: 0.418-0.898; ORno=0.684, 95%CI: 0.469-0.997), new business adaptability (OR=1.749, 95%CI: 1.325-2.309) were the influencing factors for cervical discomfort in medical staff. Conclusion The prevalence of cervical discomfort is high in medical staff. Years of service, working environment and new business adaptability are associated with cervical discomfort in medical staff.
2.Efficacy and safety of huperzine A in treating patients with mild cognitive impairment: a systematic review and Meta-analysis.
Po HUANG ; Bo LI ; Yu-Hong GUO ; Shuo FENG ; Jing HU ; Qing-Quan LIU
China Journal of Chinese Materia Medica 2019;44(3):582-588
To evaluate the efficacy and safety of huperzine in treating patients with mild cognitive impairment. The randomized controlled trials(RCT) were retrieved from EMbase, Cochrane Library, PubMed, CNKI, Wanfang and VIP. The methodology quality of the included studies was evaluated, and a Meta-analysis was performed using RevMan 5.3 software. A total of nine RCTs were included. The Meta-analysis results showed that compared with placebo, Huperzine significantly increased the scores of memory quotient(MQ) and mini-mental state examination(MMSE). However, there was no statistical difference between oral tablet and capsule. Compared with placebo, huperzine A was superior in the scores of MQ and MMSE. Huperzine is safe with mild side effects. Due to the low quality of original studies, more high-quality studies are needed to verify its efficacy.
Alkaloids
;
therapeutic use
;
Cognitive Dysfunction
;
drug therapy
;
Humans
;
Memory
;
Randomized Controlled Trials as Topic
;
Sesquiterpenes
;
therapeutic use
3.Cholesterol-associated lysosomal disorder triggers cell death of hematological malignancy: Dynamic analysis on cytotoxic effects of LW-218.
Po HU ; Hui LI ; Wenzhuo SUN ; Hongzheng WANG ; Xiaoxuan YU ; Yingjie QING ; Zhanyu WANG ; Mengyuan ZHU ; Jingyan XU ; Qinglong GUO ; Hui HUI
Acta Pharmaceutica Sinica B 2021;11(10):3178-3192
The integrity of lysosomes is of vital importance to survival of tumor cells. We demonstrated that LW-218, a synthetic flavonoid, induced rapid lysosomal enlargement accompanied with lysosomal membrane permeabilization in hematological malignancy. LW-218-induced lysosomal damage and lysosome-dependent cell death were mediated by cathepsin D, as the lysosomal damage and cell apoptosis could be suppressed by depletion of cathepsin D or lysosome alkalization agents, which can alter the activity of cathepsins. Lysophagy, was initiated for cell self-rescue after LW-218 treatment and correlated with calcium release and nuclei translocation of transcription factor EB. LW-218 treatment enhanced the expression of autophagy-related genes which could be inhibited by intracellular calcium chelator. Sustained exposure to LW-218 exhausted the lysosomal capacity so as to repress the normal autophagy. LW-218-induced enlargement and damage of lysosomes were triggered by abnormal cholesterol deposition on lysosome membrane which caused by interaction between LW-218 and NPC intracellular cholesterol transporter 1. Moreover, LW-218 inhibited the leukemia cell growth
4.Interpretation and prospect of clinical practice guideline on traditional Chinese medicine therapy alone or combined with antibiotics for sepsis.
Po HUANG ; Guo-Zhen ZHAO ; Yi-Shan CHEN ; Yan-Xiang HA ; Rui ZHANG ; Jing HU ; Shuo FENG ; Yu-Hong GUO ; Sha-Sha HE ; Xing LIAO ; Yan-Ming XIE ; Jun-Hua ZHANG ; Bo-Li ZHANG ; Bo LI ; Qing-Quan LIU
China Journal of Chinese Materia Medica 2018;43(24):4782-4785
Clinical practice guideline on traditional Chinese medicine therapy alone or combined with antibiotics for sepsis is strictly in accordance with the latest diagnostic criteria for sepsis (sepsis-3) for the treatment of septic patients at different stages through syndrome differentiation. At present, the abuse of antibiotics and the prevalence of drug-resistant bacteria are very serious, without effective solutions. Thus, this is the first time to focus on traditional Chinese medicine combined with antibiotics to treat sepsis, in order to minimize the incidence of drug-resistant bacteria. This Guideline tends to systematically analyze the sepsis period, septic shock period as well as different clinical symptoms and traditional Chinese medicine measures for organ dysfunction in the sepsis process. By analyzing and interpreting the Guideline systematically, the clinicians could understand its purpose, significance and core ideas more thoroughly, and grasp the recommended specific interventions as well as their advantages and disadvantages, hoping to better implement the Guideline, provide guidance to clinicians and standardize the treatment of sepsis by traditional Chinese medicine.
Anti-Bacterial Agents
;
therapeutic use
;
Humans
;
Medicine, Chinese Traditional
;
Sepsis
;
drug therapy
5.Clinical application evaluation and revision suggestions of clinical practice guideline on traditional Chinese medicine therapy alone or combined with antibiotics for sepsis.
Rui ZHANG ; Yi-Shan CHEN ; Guo-Zhen ZHAO ; Dong-Dong WANG ; Yan-Xiang HA ; Po HUANG ; Jing HU ; Shuo FENG ; Yu-Hong GUO ; Xing LIAO ; Yan-Ming XIE ; Jun-Hua ZHANG ; Bo-Li ZHANG ; Bo LI ; Qing-Quan LIU
China Journal of Chinese Materia Medica 2018;43(24):4776-4781
To investigate the clinical application of clinical practice guideline on traditional Chinese medicine therapy alone or combined with antibiotics for sepsis, in order to promote the follow-up revision and further promotion of the Guidelines. Copies of 500 application evaluation questionnaire and 500 copies of applicability evaluation questionnaire were given to the clinicians who had used this Guideline in China, both in a form of registered questionnaire, and a database was established by Excel 2016 for descriptive statistical analysis. Copies of 211 application evaluation questionnaire and 211 copies of applicability evaluation questionnaire were collected. We can conclude from the survey that we should adjust the whole content and structure on the basis of better evaluation of the present recommendation scheme, update the prescription selection and clinical evidence of the recommendation scheme, and put forward the improvement measures for the hindrance factors in the application of the Guideline. Furthermore, in order to promote the Guideline more clearly, we should strengthen the doctor-patient education, improve guidance quality and increase the publicity, providing basis for the implementation and promotion strategies of the Guideline.
Anti-Bacterial Agents
;
therapeutic use
;
China
;
Humans
;
Medicine, Chinese Traditional
;
Sepsis
;
drug therapy
;
Surveys and Questionnaires